Udenafil CAS:268203-93-6

CAS NO: 268203-93-6
Udenafil CAS:268203-93-6
Description Review
Description

Udenafil is a medication used to treat erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). The chemical name for Udenafil is 5-[(2-{2-ethoxy-5-[4-(pyridin-4-yl)thiazol-2-yl]phenyl}ethyl)carbamoyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one. It has the molecular formula C24H30N6O3S and a formula weight of 474.59 g/mol. The CAS number for Udenafil is 268203-93-6.

Top ten keywords from Google and Synonyms:

  1. Udenafil mechanism of action
  2. Udenafil side effects
  3. Udenafil dosage
  4. Erectile dysfunction medication
  5. Pulmonary arterial hypertension treatment
  6. Phosphodiesterase type 5 inhibitor
  7. Viagra alternative
  8. Zudena
  9. Male sexual dysfunction
  10. Nitric oxide pathway

Health benefits of this product: Udenafil is primarily used to treat erectile dysfunction and pulmonary arterial hypertension. This medication works by increasing blood flow to the penis or lungs, which can improve symptoms such as difficulty achieving or maintaining an erection or shortness of breath. By doing so, Udenafil can improve quality of life and overall well-being in patients with ED or PAH.

Potential effects: The potential effects of Udenafil can vary depending on the individual patient's condition and response to treatment. In general, this medication has been shown to be effective at improving symptoms of ED and PAH, such as difficulty achieving or maintaining an erection or shortness of breath. Udenafil can also improve overall quality of life and well-being in patients with these conditions.

Product mechanism: Udenafil belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. These medications work by blocking the action of PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP), a molecule that promotes relaxation of smooth muscle in blood vessels. By blocking the action of PDE5, Udenafil increases levels of cGMP, leading to relaxation of smooth muscle in blood vessels and increased blood flow to the penis or lungs.

Safety: Like all medications, Udenafil can cause side effects, some of which can be severe or life-threatening. It is important to discuss any concerns or questions with a healthcare provider before starting this medication. Additionally, patients who take Udenafil may need to have regular monitoring of their blood pressure and other vital signs to ensure that they are within normal limits.

Side effects: The most common side effects of Udenafil include headache, flushing, nasal congestion, and back pain. Other potential side effects include dizziness, nausea, and visual disturbances. Some patients may also experience more serious side effects, such as a sudden decrease or loss of vision or hearing, or an allergic reaction. If any side effects occur, it is important to notify a healthcare provider right away.

Dosing information: The recommended dose of Udenafil varies depending on the individual patient's condition and response to treatment. It is important to follow the dosing instructions provided by a healthcare provider and not exceed the recommended dose. Udenafil should be taken approximately 30 minutes before sexual activity or as directed by a healthcare provider, and should not be taken more than once per day.

Conclusion: Udenafil is an effective medication used to treat erectile dysfunction and pulmonary arterial hypertension. This medication works by increasing blood flow to the penis or lungs, which can improve symptoms such as difficulty achieving or maintaining an erection or shortness of breath. While generally considered safe, there are potential side effects associated with its use, and it is important to discuss any concerns with a healthcare provider. Overall, Udenafil is an important medication for people with ED or PAH that can improve quality of life and overall well-being.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code